OMCL Omnicell Inc: Rasio Total Utang marang Ekuitas

Omnicell - logo grafis emiten OMCL

Stable electronics supply chains support the growth rates of Omnicell, Inc. (OMCL). The financial stability ratio (debt-to-equity) reflects current leverage, with the indicator standing at 0.15. Dominance in the pharmacy automation niche creates a powerful barrier to customer migration. Meanwhile, the low cyclicality of demand for health IT solutions mitigates risks, although budget constraints may slow the replacement rate of expensive equipment.

OMCL - Rasio Kabeh Utang marang Dana Pribadi Omnicell ing rentang 04.07.2022 - 30.10.2026

Rincian metrik lan analitis perusahaan Omnicell Health (OMCL)

- rega saham lan konsensus proyeksi valuasi:
Rega saham Omnicell|OMCL - Target median analis
- data kapitalisasi saham perusahaan:
Biji pasar Omnicell|OMCL - Total Nilai Bisnis
- informasi kapitalisasi buku:
Nilai Akuntansi saben Saham Omnicell|OMCL - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku omnicell.com|OMCL - Gunggung Aset Perusahaan
- indikator beban utang lan likuiditas:
Total Utang marang Modal Omnicell, Inc.|OMCL - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Omnicell, Inc.|OMCL - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku Omnicell|OMCL - Utang jangka dawa|Utang jangka cendhak perusahaan Omnicell|Likuiditas cepet omnicell.com
- statistik bathi lan rasio pasar:
OMCL - Bathi perusahaan
Analisis umum perusahaan:OMCL, Omnicell
Produk dadi Omnicell Health

Omnicell, Inc. (OMCL) develops a complex medication automation infrastructure within the healthcare sector. This indicator compares total liabilities to net assets to determine the business's degree of reliance on borrowed funds. Investors analyze leverage dynamics to assess solvency and default risks. High switching costs for equipment ensure a stable cash flow for the company, mitigating over-leverage risks. The company's debt-to-equity ratio confirms the resilience of its financial strategy.

Pesaing Omnicell, Inc.

VEEV (Veeva) - Total Utang marang Modal|Doximity Inc (DOCS) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas HQY (HealthEquity Corp)|Utang Agregat marang Modal WAY|CorVel Corporation - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PRVA|HURN - Utang marang Ekuitas|Certara Inc (CERT) - Rasio Total Utang marang Ekuitas|GDRX: Total Utang marang Modal|Utang marang Modal Schrodinger Corp (SDGR)|PHR (Phreesia, Inc.) - Total Utang marang Modal|Rasio Utang marang Ekuitas OMDA (omadahealth.com)|Utang marang Ekuitas Evolent Health (EVH)|HSTM - Utang marang Modal|Utang marang Ekuitas Definitive Healthcare Inc. DH|CCSI - Rasio Total Utang marang Ekuitas|AGL - Utang marang Ekuitas|ABSI (absci.com) - Rasio Utang marang Ekuitas|SY: Total Utang marang Modal|NRC - Koefisien Total Utang marang Modal|SPOK (Spok Corp) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas OptimizeRx Inc. (OPRX)|Total Utang marang Modal TBRG|SLP - Utang marang Modal|Utang marang Ekuitas SOPHiA GENETICS SOPH|Health Catalyst Inc. - Utang marang Ekuitas|CCLD - Utang marang Ekuitas|RSSS: Utang marang Ekuitas|DLHC (dlhcorp.com) - Rasio Total Utang marang Ekuitas|OneMedNet - Rasio Kabeh Utang marang Dana Pribadi|SCNX (Scienture) - Total Utang marang Modal|Healthcare Triangle Inc (HCTI) - Koefisien Total Utang marang Modal|Utang marang Ekuitas iSpecimen Inc. (ISPC)|bullfrogai.com - Rasio Utang marang Ekuitas|Total Utang marang Modal WORX (SCWorx Corp.)|MSPR - Rasio Total Utang marang Ekuitas|ICCT: Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal TRxADE HEALTH Inc MEDS|Orgenesis Corp (ORGS) - Utang marang Ekuitas|Utang marang Modal R1 RCM (RCM)|Utang marang Ekuitas Sharecare, Inc.|Rasio Total Utang marang Ekuitas streamlinehealth.net (STRM)|Total Utang marang Modal SYRA|Rasio Total Utang marang Ekuitas apollomed.net AMEH|Utang marang Ekuitas Model N Corp MODN|NextGen Healthcare Corp - Utang marang Ekuitas